Fig. 4.
Fig. 4. Synergistic interaction of BCL2 and Myc. / Genes involved in these processes, which are deregulated by IGtranslocations, are shown in yellow. BCL2: Central to the control of apoptosis is the release of cytochrome c from the mitochondrion, resulting in activation of procaspase 9. BCL2 prevents this by maintaining ADP/ATP exchange through the voltage-dependent anion channel (VDAC) within the mitochondrial membrane, inhibiting H+ accumulation in the intermembrane space and subsequent cytochrome c release. However, BCL2 also inhibits proliferation by promoting cell cycle arrest. Myc: Myc mediates both proliferation and apoptosis. Blocking of Myc-induced apoptosis by genetic events, such as BCL2 overexpression or alterations in the p19 (ARF)–Mdm2–p53 pathway, results in unrestrained proliferation.

Synergistic interaction of BCL2 and Myc.

Genes involved in these processes, which are deregulated by IGtranslocations, are shown in yellow. BCL2: Central to the control of apoptosis is the release of cytochrome c from the mitochondrion, resulting in activation of procaspase 9. BCL2 prevents this by maintaining ADP/ATP exchange through the voltage-dependent anion channel (VDAC) within the mitochondrial membrane, inhibiting H+ accumulation in the intermembrane space and subsequent cytochrome c release. However, BCL2 also inhibits proliferation by promoting cell cycle arrest. Myc: Myc mediates both proliferation and apoptosis. Blocking of Myc-induced apoptosis by genetic events, such as BCL2 overexpression or alterations in the p19 (ARF)–Mdm2–p53 pathway, results in unrestrained proliferation.

Close Modal

or Create an Account

Close Modal
Close Modal